SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-259798
Filing Date
2009-12-24
Accepted
2009-12-24 08:59:29
Documents
8
Period of Report
2009-12-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 22346
2 FORM OF 12 PERCENT SIGN SECURED PROMISSORY NOTE dex41.htm EX-4.1 20340
3 FORM OF COMMON STOCK PURCHASE WARRANT dex42.htm EX-4.2 71610
4 OPINION OF PRYOR CASHMAN LLP dex51.htm EX-5.1 8550
5 NOTE AND WARRANT PURCHASE AGREEMENT dex101.htm EX-10.1 133581
6 PRESS RELEASE OF MDRNA INC. dex991.htm EX-99.1 7942
7 GRAPHIC g22785g07s53.jpg GRAPHIC 20527
8 GRAPHIC g22785g35p04.jpg GRAPHIC 6346
  Complete submission text file 0001193125-09-259798.txt   303424
Mailing Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021
Business Address 3830 MONTE VILLA PARKWAY BOTHELL WA 98021 4259083600
MDRNA, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 091259656
SIC: 2834 Pharmaceutical Preparations